Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 May 2026 | 28 Feb 2026 | 30 Nov 2025 | 31 May 2025 | 28 Feb 2025 | 30 Nov 2024 |
|---|---|---|---|---|---|---|
| Revenue | 8.75B | 8.28B | 8.31B | 7.83B | 6.73B | 6.99B |
| Cost of revenue | 7.92B | 7.54B | 7.56B | 7.15B | 6.15B | 6.39B |
| Gross profit | 828M | 746M | 742M | 681M | 576M | 606M |
| Research and development | 9M | 7M | 7M | 7M | 7M | 8M |
| Selling, general and administrative | 340M | 329M | 344M | 274M | 256M | 305M |
| Operating income | 445M | 374M | 283M | 403M | 245M | 197M |
| Pre-tax income | 366M | 300M | 220M | 290M | 184M | 139M |
| Income tax | 91M | 78M | 74M | 68M | 67M | 39M |
| Net income | 275M | 223M | 146M | 222M | 117M | 100M |
| Earnings per share | 2.61 | 2.10 | 1.37 | 2.05 | 1.07 | 0.89 |
| Earnings per share, diluted | 2.59 | 2.08 | 1.35 | 2.03 | 1.06 | 0.88 |
| Weighted average shares | 105M | 106M | 107M | 108M | 110M | 113M |
| Weighted average shares, diluted | 107M | 107M | 108M | 109M | 111M | 114M |
| Metric | 31 May 2026 | 28 Feb 2026 | 30 Nov 2025 | 31 Aug 2025 | 31 May 2025 | 28 Feb 2025 | 30 Nov 2024 | 31 Aug 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.36B | 1.83B | 1.57B | 1.93B | 1.52B | 1.59B | 2.06B | 2.20B |
| Inventory | 5.93B | 4.97B | 4.68B |
| Metric | 30 Nov 2025 | 30 Nov 2024 |
|---|---|---|
| Operating cash flow | 323M | 312M |
| Depreciation and amortisation | 267M | 182M |
| Capital expenditure | 95M | 97M |
| Investing cash flow | −180M | −136M |
| Dividends paid | 10M | 10M |
| Share buybacks | 300M | 232M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 4.68B |
| 4.77B |
| 4.44B |
| 4.32B |
| 4.28B |
| Current assets | 18.16B | 15.01B | 14.38B | 13.72B | 13.78B | 12.61B | 13.23B | 12.79B |
| Goodwill | 1.23B | 1.23B | 887M | 841M | 831M | 802M | 670M | 661M |
| Total assets | 23.82B | 20.63B | 19.28B | 18.54B | 18.59B | 17.40B | 17.77B | 17.35B |
| Current liabilities | 18.51B | 14.81B | 14.55B | 13.71B | 14.02B | 12.32B | 12.43B | 11.78B |
| Short-term debt | 499M | 500M | 500M | 499M | 499M | 0 | 0 | 0 |
| Long-term debt | 2.88B | 3.38B | 2.39B | 2.39B | 2.39B | 2.88B | 2.88B | 2.88B |
| Total liabilities | 22.49B | 19.28B | 17.93B | 17.03B | 17.30B | 16.04B | 16.18B | 15.61B |
| Equity | 1.32B | 1.34B | 1.34B | 1.51B | 1.29B | 1.36B | 1.59B | 1.74B |
| Shares outstanding | 105M | 106M | 107M | 107M | 107M | 110M | 112M | 114M |
| Shares issued | 279M | 279M | 279M | 278M | 278M | 278M | 277M | 276M |
| Treasury shares | 175M | 174M | 172M | 171M | 171M | 168M | 166M | 163M |
| Financing cash flow | −503M | −312M |